These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17575241)

  • 61. The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.
    Wang GY; Lu CQ; Zhang RM; Hu XH; Luo ZW
    Am J Epidemiol; 2008 Jan; 167(1):7-14. PubMed ID: 17971340
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The transforming growth factor-β receptor genes and the risk of intracranial aneurysms.
    Ruigrok YM; Baas AF; Medic J; Wijmenga C; Rinkel GJ
    Int J Stroke; 2012 Dec; 7(8):645-8. PubMed ID: 21978186
    [TBL] [Abstract][Full Text] [Related]  

  • 63. TGFBR1 polymorphism and risk of breast cancer in Iranian women.
    Kamali E; Hemmati S; Safari F; Tavassoli M
    Int J Biol Markers; 2015 Nov; 30(4):e414-7. PubMed ID: 26165686
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma.
    Gong Z; Hebert JR; Bostick RM; Deng Z; Hurley TG; Dixon DA; Nitcheva D; Xie D
    Cancer; 2007 Mar; 109(5):849-57. PubMed ID: 17236225
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
    Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.
    Dutt SS; Chen N; Darbary HK; Swede H; Petrelli NJ; Stoler DL; Anderson GR
    Mutat Res; 2008 Oct; 645(1-2):27-32. PubMed ID: 18778720
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
    Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
    Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.
    Bian Y; Knobloch TJ; Sadim M; Kaklamani V; Raji A; Yang GY; Weghorst CM; Pasche B
    Hum Mol Genet; 2007 Dec; 16(24):3128-35. PubMed ID: 17890272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure and polymorphism analysis of transforming growth factor beta receptor 1 (TGFBR1) in pigs.
    Shimanuki S; Mikawa A; Miyake Y; Hamasima N; Mikawa S; Awata T
    Biochem Genet; 2005 Oct; 43(9-10):491-500. PubMed ID: 16341765
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association between Int7G24A rs334354 polymorphism and cancer risk: a meta-analysis of case-control studies.
    Wu W; Tong Y; Wei X; Zhao Q; Pan X; Yu G; Lu Q
    Sci Rep; 2015 Jun; 5():11350. PubMed ID: 26074400
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk.
    Landi S; Bottari F; Gemignani F; Gioia-Patricola L; Guino E; Osorio A; de Oca J; Capella G; Canzian F; Moreno V;
    Eur J Cancer; 2007 Mar; 43(4):762-8. PubMed ID: 17258448
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CHEK2 I157T and colorectal cancer in Bulgaria.
    Konstantinova D; Kadiyska T; Sokolova V; Kaneva R; Mirchev M; Savov A; Aleksandrova A; Nedin D; Kostadinov E; Damyanov D; Kremensky I; Mitev V
    J BUON; 2010; 15(2):314-7. PubMed ID: 20658728
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oral contraceptives and colorectal cancer risk: a meta-analysis.
    Fernandez E; La Vecchia C; Balducci A; Chatenoud L; Franceschi S; Negri E
    Br J Cancer; 2001 Mar; 84(5):722-7. PubMed ID: 11237397
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A systematic review and meta-analysis of the association of transforming growth factor β receptor I 6A/9A gene polymorphism with ovarian cancer risk.
    Liu LL; Wei YP; Xu H; Huang Y; Luo FE; Huang ZJ; Mai H; Deng L; Yin Y
    J Recept Signal Transduct Res; 2014 Aug; 34(4):313-6. PubMed ID: 24512448
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.
    Pasche B; Wisinski KB; Sadim M; Kaklamani V; Pennison MJ; Zeng Q; Bellam N; Zimmerman J; Yi N; Zhang K; Baron J; Stram DO; Hayes MG
    J Exp Clin Cancer Res; 2010 May; 29(1):57. PubMed ID: 20500843
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TGFBR1*6A is not associated with prostate cancer in men of European ancestry.
    Suarez BK; Pal P; Jin CH; Kaushal R; Sun G; Jin L; Pasche B; Deka R; Catalona WJ
    Prostate Cancer Prostatic Dis; 2005; 8(1):50-3. PubMed ID: 15505640
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer.
    Baglietto L; Jenkins MA; Severi G; Giles GG; Bishop DT; Boyle P; Hopper JL
    J Clin Epidemiol; 2006 Feb; 59(2):114-24. PubMed ID: 16426946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TGFBR1 and cancer susceptibility.
    Pasche B; Pennison MJ; Jimenez H; Wang M
    Trans Am Clin Climatol Assoc; 2014; 125():300-12. PubMed ID: 25125747
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation.
    Rosman DS; Phukan S; Huang CC; Pasche B
    Cancer Res; 2008 Mar; 68(5):1319-28. PubMed ID: 18316594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.